rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
1994-12-16
|
pubmed:abstractText |
The aim of our study was to determine a superior thrombolytic regimen from three: anistreplase (APSAC), front-loaded recombinant tissue-type plasminogen activator (rt-PA) or combination thrombolytic therapy.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0735-1097
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
1602-10
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:7963104-Aged,
pubmed-meshheading:7963104-Anistreplase,
pubmed-meshheading:7963104-Aspirin,
pubmed-meshheading:7963104-Double-Blind Method,
pubmed-meshheading:7963104-Drug Therapy, Combination,
pubmed-meshheading:7963104-Female,
pubmed-meshheading:7963104-Follow-Up Studies,
pubmed-meshheading:7963104-Heparin,
pubmed-meshheading:7963104-Humans,
pubmed-meshheading:7963104-Infusions, Intravenous,
pubmed-meshheading:7963104-Male,
pubmed-meshheading:7963104-Middle Aged,
pubmed-meshheading:7963104-Myocardial Infarction,
pubmed-meshheading:7963104-Thrombolytic Therapy,
pubmed-meshheading:7963104-Tissue Plasminogen Activator,
pubmed-meshheading:7963104-Vascular Patency
|
pubmed:year |
1994
|
pubmed:articleTitle |
Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
|
pubmed:affiliation |
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|